Biotechnologies Assets S.A.
BST
Rank in Stocks
#26854
Biotechnologies Assets S.A. is dedicated to conceiving, producing, and... Biotechnologies Assets S.A. is dedicated to conceiving, producing, and commercializing sophisticated biotechnological assets. These innovative materials are utilized across a diverse array of sectors, including biopharmaceuticals, agriculture, cosmetics, animal health, and the broader chemical industry. The company operates globally, with its headquarters located in Cรกdiz, Spain, where it was established in 1954.
Share Price
$0.23897531
Last synced: 2026-11-11
Market Cap
$17.91M
Change (1 day)
1.88%
Change (1 year)
-33.06%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Biotechnologies Assets S.A. (BST)
Category
Healthcare
Operating Margin for Biotechnologies Assets S.A. (BST)
Operating Margin as of November 2026 TTM: -61.59%
According to Biotechnologies Assets S.A.'s latest financial reports, its current operating margin (TTM) is -61.59%. At the end of 2025 the company had an operating margin of -61.59%.
Operating Margin history for Biotechnologies Assets S.A. from 2010 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -61.59% | 0.00% |
| 2025 | -61.59% | -157.19% |
| 2024 | 107.69% | 58.58% |
| 2023 | 67.91% | 2.66% |
| 2022 | 66.15% | -198.42% |
| 2021 | -67.21% | 40.40% |
| 2020 | -47.87% | 198.44% |
| 2019 | -16.04% | -74.98% |
| 2018 | -64.10% | 480.62% |
| 2017 | -11.04% | -91.33% |
| 2016 | -127.39% | 127.20% |
| 2015 | -56.07% | -418.04% |
| 2014 | 17.63% | -29.82% |
| 2013 | 25.12% | -114.60% |
| 2012 | -172.01% | 561.07% |
| 2011 | -26.02% | -40.66% |
| 2010 | -43.85% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.63% |
US
|
|
| -149.01% | -97.58% |
US
|
|
| 25.57% | -100.42% |
AU
|
|
| 31.23% | -100.51% |
BE
|
|
| 29.35% | -100.48% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Biotechnologies Assets S.A.'s operating margin
What is Biotechnologies Assets S.A.'s operating margin?
Biotechnologies Assets S.A.'s operating margin is -61.59%, as of Nov 2026.
What was Biotechnologies Assets S.A.'s operating margin in 2025?
In 2025, Biotechnologies Assets S.A.'s operating margin was -61.59%, compared with 107.69% in 2024.
How has Biotechnologies Assets S.A.'s operating margin changed since 2020?
From 2020 to 2025, Biotechnologies Assets S.A.'s operating margin was highest in 2024 (107.69%) and lowest in 2021 (-67.21%).
How does Biotechnologies Assets S.A.'s operating margin compare with similar companies?
Biotechnologies Assets S.A.'s operating margin (-61.59%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.